HCV founder viruses as vaccine targets [ 2013 - 2015 ]

Research Grant

Researchers: Dr Rowena Bull (Principal investigator) ,  A/Pr Fabio Luciani ,  Dr Silvana Gaudieri ,  Prof Andrew Lloyd ,  Prof Steven Foung

Brief description Most individuals infected with hepatitis C virus (HCV) develop progressive liver disease. A vaccine is urgently needed, and needs to mimic the immune responses seen in the minority of individuals who clear infection. However, there are large gaps in our understanding of these responses as most acute infections cause no illness and pass unnoticed. This project will fill these gaps by detailed immunological and virological analysis of a large group of subjects with early infection.

Funding Amount $AUD 520,870.27

Funding Scheme Project Grants

Notes Standard Project Grant